iBio (IBIO) Financials

iBio Inc (IBIO) is a biotechnology company focused on the development and commercialization of plant-based vaccines and therapeutics. The company's financials provide insight into its performance and financial health. The income statement reflects the company's revenue and expenses, including gross profit and net income from stockholders. The total revenue indicates the overall sales generated by iBio Inc. The balance sheet highlights the company's assets, liabilities, and stockholders' equity. Cash equivalents represent the company's short-term investments that are readily convertible into cash. Net debt is the total debt minus cash and cash equivalents. Stockholders' equity represents the value of the company attributable to its shareholders. Total assets reflect the company's resources, including cash, investments, and property. Total debt shows the company's long-term and short-term liabilities. Total liabilities represent the company's obligations. The cash flow statement showcases the company's cash inflows and outflows. It includes operating cash flow, which measures the company's cash generated from its core operations. Investing cash flow represents the cash used for acquiring or disposing of assets. Financing cash flow reflects the company's cash from issuing or repurchasing its own securities, such as stocks or bonds. Free cash flow is the cash left after deducting capital expenditures from operating cash flow. iBio Inc's financials provide a comprehensive view of its financial performance and position in the market.

iBio Inc (IBIO) is a biotechnology company that focuses on the development and commercialization of plant-based vaccines and therapeutics. The company's financials play a crucial role in assessing its financial health and performance. EBIT, or earnings before interest and taxes, is a measure of a company's operating profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, provides a clearer picture of a company's operating performance by excluding non-operating expenses. Gross profit is the difference between revenue and the cost of goods sold. Net income from stockholders indicates the profit available to the company's shareholders after all expenses, including taxes and interest, have been paid. The total revenue reflects the company's sales and indicates its market position. The balance sheet provides a snapshot of the company's financial position by showing its assets, liabilities, and stockholders' equity. Cash equivalents refer to short-term investments that are highly liquid and easily convertible into cash. Net debt is the company's total debt minus its cash and cash equivalents. Stockholders' equity represents the residual interest in the company's assets after deducting liabilities. Total assets reflect the company's resources, including cash, inventory, and property. Total debt is the aggregate amount of a company's outstanding debt. Total liabilities represent the company's obligations to external parties. The cash flow statement shows how the company generates and uses cash over a specific period. Operating cash flow presents the cash generated from the company's day-to-day operations. Investing cash flow represents the cash used for acquiring or selling assets. Financing cash flow includes cash from issuing or buying back the company's own securities. Free cash flow is the cash available after deducting capital expenditures. iBio Inc's financials provide valuable insights into its financial performance and stability in the market.